CLEMSON — A new company emerging from Clemson University research aims to commercialize medical simulator technology that will offer medical educators a more effective alternative for the training of critical procedures, according to the Clemson University Research Foundation.

MedUSim Solutions, led by Jiro Nagatomi and Delphine Dean of the bioengineering department at Clemson University, is developing cost-effective, accurate medical skill-training simulators that are designed with teaching effectiveness in mind. Their leading product, a next-generation center venous catheterization trainer, CLiVE (Central Line Vascular Emulator), is designed to provide a low-cost, comprehensive training platform with realistic replacement parts.

“Medical educators who train doctors provide us invaluable feedback for our product,” said Nagatomi. “This essential feedback enables the MedUSim team to identify the critical skills that cannot be learned with existing products on the market and the CLiVE product to be designed better.”

Nagatomi and Dean recently received a $25,000 seed grant from SC Launch, a startup-assistance program by South Carolina Research Authority, and are currently seeking additional capital and personnel.

END

Clemson University Research Foundation
The Clemson University Research Foundation (CURF) is a nonprofit corporation that facilitates the transfer of Clemson University’s intellectual property to the private sector for commercial development and societal benefit.  To learn more about CURF services and to view current technologies available for license, visit www.clemson.edu/curf

MedUSim Solutions
The mission of MedUSim Solutions is to develop safe, affordable and accurate medical skill-training devices that are designed with teaching effectiveness in mind. Our leading product is a next generation central venous catheterization trainer, CLiVE (Central Line Vascular Emulator). MedUSim Solutions is a Clemson University spinoff company located in Clemson, S.C.